A clinical study assessing the tolerability and biological effects of infliximab, a TNF-alpha inhibitor, in patients with advanced cancer.
Brown ER, Charles KA, Hoare SA, Rye RL, Jodrell DI, Aird RE, Vora R, Prabhakar U, Nakada M, Corringham RE, DeWitte M, Sturgeon C, Propper D, Balkwill FR, Smyth JF.
Ann Oncol. 2008 Jul;19(7):1340-6. Epub 2008 Mar 5.PMID: 18325912 [PubMed - indexed for MEDLINE]Related articlesFree article